Literature DB >> 3567903

Identification and androgen regulation of two proteins released by T47D human breast cancer cells.

D Chalbos, D Haagensen, T Parish, H Rochefort.   

Abstract

Three [35S]methionine-labeled polypeptides released by T47D human breast cancer cells have been identified as corresponding to two proteins previously described in breast gross cystic disease fluid. A Mr 43,000 protein was immunoprecipitated by polyclonal antibodies to the Zn-alpha 2-glycoprotein. A Mr 18,000 and a Mr 13,000 polypeptide were both immunoprecipitated by four monoclonal antibodies directed against four separate epitopes of Mr 15,000 gross cystic disease fluid protein, a major protein that is characteristic of apocrine gland secretions. In sodium dodecyl sulfate-polyacrylamide gel electrophoresis, purified Mr 15,000 gross cystic disease fluid protein migrated at the level of the Mr 18,000 protein of T47D cells. The proteins were regulated by androgens and progestins. In addition to a general stimulation of protein secretion, 5 alpha-dihydrotestosterone (DHT) specifically increased, by 2- to 20-fold, the release of the Mr 43,000 and Mr 18,000 proteins into the medium. DHT also increased the cellular level of the Mr 18,000 protein, as shown by immunoprecipitation with a Mr 15,000 gross cystic disease fluid protein antibody, which suggests a stimulation of protein synthesis. The progestin 17,21-dimethyl-19-nor-4,9-pregnadiene-3,20-dione also increased the release in the medium of the Mr 43,000 and Mr 18,000 proteins, but higher molar concentrations were required than in the case of DHT. The induction of these proteins by DHT and 17,21-dimethyl-19nor,4,9-pregnadiene-3,20-dione was specifically inhibited by the antiandrogen flutamide which has no effect on other progestin-regulated proteins. This suggests an effect mediated by the androgen receptor. This is the first report on the identification of two proteins induced by androgens in a human breast cancer cell line. These proteins should be useful in studying the role of androgens in human mammary tumors and their mechanism of action in cell culture.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3567903

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

Review 1.  Role of the androgen receptor in human breast cancer.

Authors:  S N Birrell; R E Hall; W D Tilley
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-01       Impact factor: 2.673

2.  Increased JNK1 activity contributes to the upregulation of ApoD in the apocrine secretory gland cells from axillary osmidrosis.

Authors:  Hui Chen; Yingli Li; Jie Du; Yan Cao; Xiaoli Li
Journal:  Mol Cell Biochem       Date:  2011-04-28       Impact factor: 3.396

3.  Inhibitory effect of androgens on DMBA-induced mammary carcinoma in the rat.

Authors:  S Dauvois; S M Li; C Martel; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1989-12       Impact factor: 4.872

4.  Expression of Zn-alpha 2-glycoprotein and PSP-94 in prostatic adenocarcinoma. An immunohistochemical study of 88 cases.

Authors:  S Gagnon; B Têtu; J Y Dubé; R R Tremblay
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

5.  Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line.

Authors:  R Poulin; D Baker; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1988-10       Impact factor: 4.872

6.  Glucocorticoids and androgens up-regulate the Zn-alpha 2-glycoprotein messenger RNA in human breast cancer cells.

Authors:  Y S López-Boado; I Díez-Itza; J Tolivia; C López-Otín
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

7.  Expression and prognostic significance of apolipoprotein D in breast cancer.

Authors:  I Díez-Itza; F Vizoso; A M Merino; L M Sánchez; J Tolivia; J Fernández; A Ruibal; C López-Otín
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

8.  Secretion of breast gross cystic disease fluid proteins by T47D breast cancer cells in culture--modulation by steroid hormones.

Authors:  D E Haagensen; P Stewart; W G Dilley; S A Wells
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

9.  Prolactin-induced protein (PIP) regulates proliferation of luminal A type breast cancer cells in an estrogen-independent manner.

Authors:  Sanjeev K Baniwal; Nyam-Osor Chimge; V Craig Jordan; Debu Tripathy; Baruch Frenkel
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

10.  Postmenopausal estrogen and progestin effects on the serum proteome.

Authors:  Sharon J Pitteri; Samir M Hanash; Aaron Aragaki; Lynn M Amon; Lin Chen; Tina Busald Buson; Sophie Paczesny; Hiroyuki Katayama; Hong Wang; Melissa M Johnson; Qing Zhang; Martin McIntosh; Pei Wang; Charles Kooperberg; Jacques E Rossouw; Rebecca D Jackson; Joann E Manson; Judith Hsia; Simin Liu; Lisa Martin; Ross L Prentice
Journal:  Genome Med       Date:  2009-12-24       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.